Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixim medicated plaster versus placebo for acute soft tissue injury pain
2021-003778-30Phase 3Completed
- Sponsor
- Drossapharm
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of etofenamate in musculoskeletal trauma, sprain, muscle strain and 1 more (2 arms), sponsored by Drossapharm. Primary endpoint: Change from baseline in pain on movement at 72 hours. Started Oct 2021; status: completed.
02
Drugs
etofenamate
03
Conditions
musculoskeletal traumasprainmuscle strainbruise
Beyond the preview
Go deeper on 2021-003778-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003778-30.